StockDrifts LogoStockDrifts

Harim Holdings 003380

Company
하림지주Harim Holdings
Insiders
2
Buys
33
Total Value
₩16.9B ($11.7M)
Avg Return
+62.49%
Last Filing
2026-06-26

Harim Holdings (003380) has 33 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩16.9B ($11.7M) in reported transaction value. The earliest filing StockDrifts holds for Harim Holdings is dated 2025-11-13; the most recent is 2026-06-26. Across these filings the average return since disclosure is +62.49%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-06-26BUYMarket Buy
권지은
Kwon Ji-eun
Managing Director1.0K₩9,130+0.0%₩9M ($6K)
2026-05-28BUYMarket Buy
한국바이오텍
Korea Biotech
-63.9K₩11,330+0.0%₩724M ($503K)
2026-05-22BUYMarket Buy
한국바이오텍
Korea Biotech
-50.0K₩12,170-6.9%₩609M ($423K)
2026-05-21BUYMarket Buy
한국바이오텍
Korea Biotech
-49.7K₩12,060-6.0%₩599M ($416K)
2026-05-20BUYMarket Buy
한국바이오텍
Korea Biotech
-5.0K₩11,750-3.6%₩58M ($40K)
2026-05-19BUYMarket Buy
한국바이오텍
Korea Biotech
-50.0K₩12,070-6.1%₩604M ($419K)
2026-05-18BUYMarket Buy
한국바이오텍
Korea Biotech
-7.7K₩12,300-7.9%₩95M ($66K)
2026-03-12BUYMarket Buy
한국바이오텍
Korea Biotech
-158.2K---
2026-03-11BUYMarket Buy
한국바이오텍
Korea Biotech
-69.3K---
2026-03-10BUYMarket Buy
한국바이오텍
Korea Biotech
-17.9K---
2026-03-09BUYMarket Buy
한국바이오텍
Korea Biotech
-8.0K---
2026-03-06BUYMarket Buy
한국바이오텍
Korea Biotech
-200.0K---
2026-03-04BUYMarket Buy
한국바이오텍
Korea Biotech
-15.0K---
2026-02-20BUYMarket Buy
한국바이오텍
Korea Biotech
-31.6K₩16,660+0.8%₩526M ($366K)
2026-02-19BUYMarket Buy
한국바이오텍
Korea Biotech
-70.0K₩16,640+0.9%₩1.2B ($809K)
2025-12-12BUYMarket Buy
한국바이오텍
Korea Biotech
-60.0K₩12,550+33.8%₩753M ($523K)
2025-12-11BUYMarket Buy
한국바이오텍
Korea Biotech
-11.3K₩11,530+45.6%₩130M ($90K)
2025-12-10BUYMarket Buy
한국바이오텍
Korea Biotech
-175.0K₩8,870+89.3%₩1.6B ($1.1M)
2025-12-09BUYMarket Buy
한국바이오텍
Korea Biotech
-37.3K₩8,710+92.8%₩325M ($225K)
2025-12-08BUYMarket Buy
한국바이오텍
Korea Biotech
-95.3K₩9,120+84.1%₩869M ($604K)
2025-12-01BUYMarket Buy
한국바이오텍
Korea Biotech
-147.9K₩8,380+100.4%₩1.2B ($861K)
2025-11-28BUYMarket Buy
한국바이오텍
Korea Biotech
-92.9K₩8,390+100.1%₩779M ($541K)
2025-11-27BUYMarket Buy
한국바이오텍
Korea Biotech
-125.6K₩8,110+107.0%₩1.0B ($708K)
2025-11-26BUYMarket Buy
한국바이오텍
Korea Biotech
-102.5K₩8,210+104.5%₩842M ($585K)
2025-11-25BUYMarket Buy
한국바이오텍
Korea Biotech
-84.3K₩8,020+109.3%₩676M ($469K)
2025-11-21BUYMarket Buy
한국바이오텍
Korea Biotech
-83.4K₩8,140+106.3%₩679M ($471K)
2025-11-20BUYMarket Buy
한국바이오텍
Korea Biotech
-43.1K₩8,250+103.5%₩356M ($247K)
2025-11-19BUYMarket Buy
한국바이오텍
Korea Biotech
-85.0K₩7,970+110.7%₩678M ($471K)
2025-11-18BUYMarket Buy
한국바이오텍
Korea Biotech
-135.0K₩7,980+110.4%₩1.1B ($748K)
2025-11-17BUYMarket Buy
한국바이오텍
Korea Biotech
-111.0K₩8,320+101.8%₩924M ($641K)
2025-11-14BUYMarket Buy
권지은
Kwon Ji-eun
moving2.5K₩8,130+106.5%₩20M ($14K)
2025-11-14BUYMarket Buy
한국바이오텍
Korea Biotech
-31.0K₩8,130+106.5%₩252M ($175K)
2025-11-13BUYMarket Buy
한국바이오텍
Korea Biotech
-43.0K₩8,250+103.5%₩355M ($246K)

Frequently asked questions

Who has been buying Harim Holdings stock?
2 distinct insiders have filed 33 disclosed insider purchases in Harim Holdings (003380), most recently on 2026-06-26. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Harim Holdings have?
Harim Holdings has 33 buy-side and 0 sell-side disclosures on record, covering ₩16.9B ($11.7M) in total reported value, spanning 2025-11-13 to 2026-06-26.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.